Bill
Bill > SR32
NJ SR32
NJ SR32Urges relevant State licensing boards to implement continuing education requirements on topics related to opioid pain medication.
summary
Introduced
01/13/2026
01/13/2026
In Committee
01/13/2026
01/13/2026
Crossed Over
Passed
Dead
Introduced Session
2026-2027 Regular Session
Bill Summary
This resolution urges the State Boards of Medical Examiners, Dentistry, Nursing, and Pharmacy to implement continuing education requirements on topics related to opioid pain medication, including responsible prescribing practices, alternatives to opioid medication for managing and treating pain, and the risks and signs of opioid misuse, abuse, and addiction. The boards are also urged to ensure that the continuing education requirements would remain in effect for the next biennial period for the renewal of professional licenses, registrations, or certifications, unless the time period is extended by the boards, and apply to physicians, physician assistants, advance practice nurses, dentists, pharmacists, professional nurses, practical nurses, and other health care professionals with the authority to prescribe opioid pain medication and those who do not have prescribing authority but frequently interact with patients who may be prescribed opioids.
AI Summary
This resolution urges state licensing boards for medical professionals, including doctors, dentists, nurses, and pharmacists, to require continuing education on opioid pain medication. This education should cover safe prescribing, alternative pain management methods, and recognizing signs of opioid misuse, abuse, and addiction. The resolution also calls for these requirements to be in place for at least two renewal periods for professional licenses and to apply to all healthcare professionals who prescribe or frequently interact with patients receiving opioid pain medication. This initiative is part of a broader effort in New Jersey to address the opioid crisis, building upon existing programs like the New Jersey Prescription Monitoring Program, which tracks controlled substance prescriptions to prevent diversion and abuse.
Committee Categories
Business and Industry
Sponsors (1)
Last Action
Introduced in the Senate, Referred to Senate Commerce Committee (on 01/13/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2026/SR32 |
| BillText | https://pub.njleg.gov/Bills/2026/SR/32_I1.HTM |
Loading...